News

A new study led by researchers at Lund University in Sweden reveals that melanoma can, in some cases, be driven by mitochondrial processes, which can be effectively targeted using existing drugs.

Researchers have developed a bioengineered hydrogel platform capable of preserving patient-derived tumor tissues for longer periods, a breakthrough that could enhance drug testing for abdominal cancer.

Researchers have pioneered a novel 3D platform that mimics the human bone marrow and immune environment, enabling more predictive testing of cancer immunotherapy success in patients, including CAR T cell therapies.

A potential treatment for glioblastoma crafted by scientists at The Wertheim UF Scripps Institute renders the deadly brain cancer newly sensitive to both radiation and chemotherapy drugs, and blocks the cancer’s ability to invade other tissues.

Some chemotherapy agents cause mutations and premature ageing in healthy blood, new research shows.

New cutting-edge software developed in Melbourne can help uncover how the most common heart tumor in children forms and changes. The technology has the potential to further our understanding of other childhood diseases, according to a new study.

A new genomic test has been developed to accurately predict whether a patient’s cancer will resist common chemotherapy treatments.

Researchers have developed a new alternative to mammography for breast imaging. The technique, photoacoustic computed tomography (PACT) uses a laser-sonic scanner and machine learning to identify tumors in as little as 15 seconds.

Researchers discovered that women treated with unopposed estrogen hormone therapy (E-HT) were less likely to develop breast cancer than those who did not use hormone therapy.

The tech demonstrated the ability to automate tumor segmentation with high consistency across hospitals and scan types.